UTHR

UNITED THERAPEUTICS Corp

SEC CIK 1082554
$536.59 +13.4% · 90 days
90-day buys
$0
0 open-market
90-day sells
$272.52M
521 open-market
Net insider flow
−$272.52M
Net selling
Filings shown
726
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at UTHR have sold a net $272.52M of stock (0 open-market buys vs 521 sells).

Largest recent trade: Mahon Paul A sold $2.88M of UTHR, trimming their stake 17%.

Most active filer: Rothblatt Martine A, with 428 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for UTHR, newest first
View on SEC EDGAR ↗
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −0.6%

Rothblatt Martine A sold $132.7K of UTHR, trimming their stake 1%.

−$132.7K
240 sh @ $553
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −1.0%

Rothblatt Martine A sold $221.8K of UTHR, trimming their stake 1%.

−$221.8K
400 sh @ $554
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −5.0%

Edgemond James sold $784.7K of UTHR, trimming their stake 5%.

−$784.7K
1,440 sh @ $545
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −9.2%

Edgemond James sold $1.38M of UTHR, trimming their stake 9%.

−$1.38M
2,520 sh @ $546
Advertisement
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −5.4%

Edgemond James sold $740.8K of UTHR, trimming their stake 5%.

−$740.8K
1,354 sh @ $547
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −6.8%

Edgemond James sold $880.5K of UTHR, trimming their stake 7%.

−$880.5K
1,606 sh @ $548
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −5.4%

Edgemond James sold $650.9K of UTHR, trimming their stake 5%.

−$650.9K
1,185 sh @ $549
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −4.9%

Edgemond James sold $558.4K of UTHR, trimming their stake 5%.

−$558.4K
1,015 sh @ $550
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −1.0%

Edgemond James sold $110.2K of UTHR, trimming their stake 1%.

−$110.2K
200 sh @ $551
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −1.4%

Edgemond James sold $154.8K of UTHR, trimming their stake 1%.

−$154.8K
280 sh @ $553
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −2.1%

Edgemond James sold $221.8K of UTHR, trimming their stake 2%.

−$221.8K
400 sh @ $554
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −0.6%

Rothblatt Martine A sold $153.6K of UTHR, trimming their stake 1%.

−$153.6K
280 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −1.5%

Rothblatt Martine A sold $422.6K of UTHR, trimming their stake 2%.

−$422.6K
769 sh @ $550
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −3.3%

Rothblatt Martine A sold $883.7K of UTHR, trimming their stake 3%.

−$883.7K
1,605 sh @ $551
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −2.1%

Rothblatt Martine A sold $543.6K of UTHR, trimming their stake 2%.

−$543.6K
986 sh @ $551
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −1.5%

Rothblatt Martine A sold $375.8K of UTHR, trimming their stake 1%.

−$375.8K
680 sh @ $553
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −1.8%

Rothblatt Martine A sold $455.7K of UTHR, trimming their stake 2%.

−$455.7K
823 sh @ $554
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −1.8%

Rothblatt Martine A sold $453.1K of UTHR, trimming their stake 2%.

−$453.1K
817 sh @ $555
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −2.3%

Rothblatt Martine A sold $555.6K of UTHR, trimming their stake 2%.

−$555.6K
1,000 sh @ $556
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −1.1%

Rothblatt Martine A sold $256.6K of UTHR, trimming their stake 1%.

−$256.6K
461 sh @ $557
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −2.2%

Rothblatt Martine A sold $512.1K of UTHR, trimming their stake 2%.

−$512.1K
918 sh @ $558
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −2.0%

Rothblatt Martine A sold $470K of UTHR, trimming their stake 2%.

−$470K
841 sh @ $559
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 3w ago ΔOwn −0.8%

Rothblatt Martine A sold $179K of UTHR, trimming their stake 1%.

−$179K
320 sh @ $559
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 3w ago ΔOwn −1.1%

Edgemond James sold $179.7K of UTHR, trimming their stake 1%.

−$179.7K
320 sh @ $561
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 3w ago ΔOwn −6.9%

Edgemond James sold $1.1M of UTHR, trimming their stake 7%.

−$1.1M
1,961 sh @ $563
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 3w ago ΔOwn −6.3%

Edgemond James sold $944.5K of UTHR, trimming their stake 6%.

−$944.5K
1,675 sh @ $564
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 3w ago ΔOwn −4.8%

Edgemond James sold $682.3K of UTHR, trimming their stake 5%.

−$682.3K
1,208 sh @ $565
Advertisement

About UTHR insider activity

This page tracks every recent Form 4 filed for UNITED THERAPEUTICS Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is UTHR insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for UNITED THERAPEUTICS Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.